The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions

References

• HayrehSSPrevalent misconceptions about acute retinal vascular occlusive disordersProg Retin Eye Res200524449351915845346
   PubMed Web of Science ®Google Scholar
• WongTYLarsenEKKleinRCardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studiesOphthalmology2005112454054715808241
   PubMed Web of Science ®Google Scholar
• MitchellPSmithWChangAPrevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye StudyArch Ophthalmol199611410124312478859084
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEMossSEMeuerSMThe epidemiology of retinal vein occlusion: the Beaver Dam Eye StudyTrans Am Ophthalmol Soc20009813314111190017
   PubMedGoogle Scholar
• KleinRMossSEMeuerSMKleinBEThe 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye StudyArch Ophthalmol2008126451351818413521
   PubMedGoogle Scholar
• CugatiSWangJJRochtchinaEMitchellPTen-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye StudyArch Ophthalmol2006124572673216682596
   PubMed Web of Science ®Google Scholar
• The Royal College of Ophthalmologists [homepage on the Internet]The Royal College of Ophthalmologists Clinical Guidelines: Retinal Vein Occlusion (RVO) Guidelines2015 Available from: http://www.rcophth.ac.ukAccessed May 15, 2017
   Google Scholar
• The Central Vein Occlusion Study Group: evaluation of grid pattern photocoagulation for macular edema in central vein occlusionOphthalmology1995102142514339097788
   PubMed Web of Science ®Google Scholar
• The Branch Vein Occlusion Study Group: argon laser photocoagulation for macula edema in branch vein occlusionAm J Ophthalmol1984982712826383055
   PubMed Web of Science ®Google Scholar
• ScottIUIpMSVanVeldhuisenPCSCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6Arch Ophthalmol200912791115112819752420
   PubMedGoogle Scholar
• IpMSScottIUVanVeldhuisenPCSCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5Arch Ophthalmol200912791101111419752419
   PubMedGoogle Scholar
• AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med199433122148014877526212
   PubMed Web of Science ®Google Scholar
• NomaHFunatsuHMimuraTIncrease of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular edema and central retinal vein occlusionActa Ophthalmol201088664665119563372
   PubMed Web of Science ®Google Scholar
• CampochiaroPAAnti-vascular endothelial growth factor treatment for retinal vein occlusionsOphthalmologica2012227suppl 1303510.1159/00033715722517123
   PubMed Web of Science ®Google Scholar
• MitryDBunceCCharterisDAnti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusionCochrane Database Syst Rev20131CD009510
   Google Scholar
• BraithwaiteTNanjiAALindsleyKGreenbergPBAnti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusionCochrane Database Syst Rev20145CD007325
   PubMed Web of Science ®Google Scholar
• HöhAESchaalKBDithmarSCentral and branch retinal vein occlusion: current strategies for treatment in Germany, Austria and SwitzerlandOphthalmologe2007104429029417387482
   PubMed Web of Science ®Google Scholar
• ParkCHScottAWFekratSEffect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusionRetina20072781020102518040238
   PubMed Web of Science ®Google Scholar
• WrightJKFranklinBZantEClinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygenUndersea Hyperb Med200734531531918019081
   PubMed Web of Science ®Google Scholar
• ArevaloJFGarciaRAWuLRadial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina study group (PACORES)Retina20082881044105218779709
   PubMed Web of Science ®Google Scholar
• KumagaiKOginoNFurukawaMLarsonEThree treatments for macular edema because of branch retinal vein occlusion: intravitreous bevacizumab or tissue plasminogen activator, and vitrectomyRetina201232352052921811207
   PubMed Web of Science ®Google Scholar
• ParkDHKimITLong-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusionRetina201030111712419996831
   PubMed Web of Science ®Google Scholar
• WeissJNBynoeLAInjection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusionOphthalmology2001108122249225711733266
   PubMed Web of Science ®Google Scholar
• GewailyDGreenbergPBIntravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionCochrane Database Syst Rev20091CD007324
   Google Scholar
• RosenfeldPJFungAEPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusionOphthalmic Surg Lasers Imaging200536433633916156153
   PubMedGoogle Scholar
• BadalàFThe treatment of branch retinal vein occlusion with bevacizumabCurr Opin Ophthalmol200819323423818408499
   PubMed Web of Science ®Google Scholar
• HikichiTHiguchiMMatsushitaTTwo-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusionBr J Ophthalmol201498219519924215032
   PubMed Web of Science ®Google Scholar
• GregoriNZGaitanJRosenfeldPJLong-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusionRetina20082891325133719430392
   PubMed Web of Science ®Google Scholar
• EpsteinDLAlgverePVvon WendtGSeregardSKvantaABenefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized studyOphthalmology2012119122587259122902212
   PubMed Web of Science ®Google Scholar
• CampochiaroPAHafizGMirTAScatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trialOphthalmology201512271426143725972260
   PubMed Web of Science ®Google Scholar
• LipPLMalickHDamerKOne-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UKClin Ophthalmol201591779178426445525
   PubMedGoogle Scholar
• BrownDMCampochiaroPABhisitkulRBSustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III studyOphthalmology201111881594160221684606
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMAwhCCSustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology2011118102041204921715011
   PubMed Web of Science ®Google Scholar
• NarayananRPanchalBDasTA randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1Br J Ophthalmol201599795495925631483
   PubMed Web of Science ®Google Scholar
• SCORE Study Research GroupA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6Arch Ophthalmol200912791115112819752420
   PubMedGoogle Scholar
• MartinDFMaguireMGYingGSRanibizumab and bevacizumab for neovascular age-related macular degenerationN Engl J Med2011364201897190821526923
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Clinical Research NetworkWellsJAGlassmanARAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med2015372131193120325692915
   PubMed Web of Science ®Google Scholar